Stay updated with breaking news from Vivek jain. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Analog Devices (NASDAQ:ADI – Free Report) had its price target lifted by Sanford C. Bernstein from $200.00 to $220.00 in a report released on Thursday, Benzinga reports. Sanford C. Bernstein currently has a market perform rating on the semiconductor company’s stock. A number of other equities analysts also recently issued reports on ADI. JPMorgan Chase […] ....
Analog Devices (NASDAQ:ADI – Free Report) had its target price hoisted by Morgan Stanley from $221.00 to $260.00 in a research report sent to investors on Thursday morning, Benzinga reports. They currently have an overweight rating on the semiconductor company’s stock. Several other equities analysts also recently issued reports on the stock. Susquehanna raised their […] ....
Indian drugmakers, which have the U.S. market as a key segment, will sustain their revenue improvement in fiscal 2025 due to drug shortages in the United States, Mumbai-based India Ratings and. ....
Indian drugmakers, such as Dr Reddy s, Cipla, and Sun Pharma, are projected to maintain revenue growth in fiscal 2025, driven by drug shortages in the U.S. market. With 233 drugs in short supply, Indian companies are poised to benefit from the challenges faced by U.S.-based generic pharma manufacturers, leading to improved financial performance and increased market share in therapeutic categories. ....
Health: Indian drugmakers to see FY25 revenue boost in key US market, says India Ratings and Research gdnonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gdnonline.com Daily Mail and Mail on Sunday newspapers.